Valuation: Abbott Laboratories

Market Cap 173B 155B 144B 131B 247B 16,681B 249B 1,739B 677B 8,514B 650B 636B 27,367B P/E 2026 *
29.3x
P/E 2027 * 22.7x
Enterprise Value 197B 176B 164B 149B 281B 18,987B 283B 1,980B 770B 9,691B 740B 724B 31,149B EV / Sales 2026 *
3.93x
EV / Sales 2027 * 3.56x
Free-Float
86.16%
Yield 2026 *
2.57%
Yield 2027 * 2.74%
1 day+2.67%
1 week-0.87%
Current month+1.29%
1 month-7.60%
3 months+4.93%
6 months-2.69%
Current year-20.11%
1 week 95.06
Extreme 95.06
100.7
1 month 95.06
Extreme 95.06
108.39
Current year 81.97
Extreme 81.97
129.46
1 year 81.97
Extreme 81.97
135.12
3 years 81.97
Extreme 81.97
141.23
5 years 81.97
Extreme 81.97
142.6
10 years 37.38
Extreme 37.38
142.6
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2020
Director of Finance/CFO 53 01/09/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 09/12/2011
Director/Board Member 67 09/12/2011
Director/Board Member 71 16/02/2017
Date Insider Type Main position Quantity % Market Cap. Importance
30/9/26 Free

Director

333 0.0000%
30/9/26 Free

Director

318 0.0000%
30/9/26 Free

Director

381 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+2.67%-0.87%-25.63%+4.05% 169B
+1.84%-1.71%-9.96%+15.52% 110B
+3.55%+3.60%-23.02%+7.71% 106B
+1.19%-1.10%-48.90%-11.35% 73.87B
+1.90%+3.66%+4.02%+70.20% 58.98B
+1.39%+6.95%+10.08%+66.27% 51.28B
+2.19%-1.72%-6.68%-30.79% 48.16B
+1.67%-0.38%-16.50%+22.43% 40.84B
+1.80%+0.25%+29.60%+3.45% 32.21B
+0.53%+2.08% - - 31.24B
Average +1.87%+0.68%-9.66%+16.39% 72.14B
Weighted average by Cap. +2.15%+0.42%-15.58%+13.70%

Financials

2026 *2027 *
Net sales 50.2B 44.78B 41.72B 37.97B 71.5B 4,835B 72.03B 504B 196B 2,468B 188B 184B 7,932B 54.53B 48.64B 45.32B 41.24B 77.67B 5,251B 78.24B 548B 213B 2,680B 205B 200B 8,615B
Net income 6.21B 5.54B 5.16B 4.7B 8.85B 598B 8.91B 62.39B 24.27B 305B 23.32B 22.82B 982B 7.89B 7.04B 6.56B 5.97B 11.24B 760B 11.33B 79.27B 30.84B 388B 29.63B 28.99B 1,247B
Net Debt 23.94B 21.36B 19.9B 18.11B 34.1B 2,305B 34.35B 240B 93.53B 1,177B 89.87B 87.93B 3,782B 20.96B 18.7B 17.42B 15.85B 29.85B 2,018B 30.07B 210B 81.88B 1,030B 78.67B 76.98B 3,311B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
05/10/26 US$100.10 +2.67% 11,985,715
02/10/26 US$97.50 +0.84% 8,709,933
01/10/26 US$96.69 -2.17% 8,862,865
30/09/26 US$98.83 -2.10% 7,571,495
29/09/26 US$100.95 -0.03% 8,049,113
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
100.10USD
Average target price
120.74USD
Spread / Average Target
+20.62%

Quarterly revenue - Rate of surprise